Amneal: 2Q Earnings Snapshot
HAYWARD, Calif. (AP) _ Amneal Pharmaceuticals, Inc. (AMRX) on Thursday reported a loss of $19.1 million in its second quarter.
On a per-share basis, the Hayward, California-based company said it had a loss of 15 cents. Earnings, adjusted for restructuring costs and non-recurring costs, were 24 cents per share.
The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of 23 cents per share.
The pharmaceutical company posted revenue of $413.8 million in the period. Its adjusted revenue was $462.3 million, falling short of Street forecasts. Six analysts surveyed by Zacks expected $463.6 million.
Amneal expects full-year earnings in the range of 90 cents to $1 per share.
Amneal shares have risen 21 percent since the beginning of the year. The stock has climbed 34 percent in the last 12 months.